Search

Your search keyword '"Lemmen, S."' showing total 287 results
Start Over Author "Lemmen, S."
287 results on '"Lemmen, S."'

1. Impact of single-room contact precautions on hospital-acquisition and transmission of multidrug-resistant Escherichia coli: a prospective multicentre cohort study in haematological and oncological wards

Author

Biehl, L.M., Higgins, P., Wille, T., Peter, K., Hamprecht, A., Peter, S., Dörfel, D., Vogel, W., Häfner, H., Lemmen, S., Panse, J., Rohde, H., Klupp, E.-M., Schafhausen, P., Imirzalioglu, C., Falgenhauer, L., Salmanton-García, J., Stecher, M., Vehreschild, J.J., Seifert, H., and Vehreschild, M.J.G.T.

Published
2019
Full Text
View/download PDF

14. Antiinfektive Therapie

Author

D., Adam, W., Christ, D., Hofmann, H., Kemmler, J., Knobloch, N., Lehn, Lemmen, S. W., H., Lode, R., Mertens, Naber, K. G., W., Preiser, K., Riecke, M., Ruhnke, R., Stahlmann, W., Vahlensieck, M., Weiß, Adam, D., editor, Doerr, H. W., editor, Link, H., editor, and Lode, H., editor

Published
2004
Full Text
View/download PDF

25. Prospective surveillance of drain associated meningitis/ventriculitis in a neurosurgery and neurological intensive care unit

Author

Scheithauer, S., Burgel, U., Ryang, Y.-M., Haase, G., Schiefer, J., Koch, S., Hafner, H., and Lemmen, S.

Subjects
Meningitis -- Distribution, Meningitis -- Risk factors, Meningitis -- Research, Intensive care units -- Research, Spine -- Puncture, Spine -- Complications and side effects, Spine -- Research, Company distribution practices, Health, Psychology and mental health
Published
2009

38. Impact of single-room contact precautions on hospital-acquisition and transmission of multidrug-resistant Escherichia coli: a prospective multicentre cohort study in haematological and oncological wards

Author

Biehl, L. M., Higgins, P., Wille, T., Peter, K., Hamprecht, A., Peter, S., Doerfel, D., Vogel, W., Haefner, H., Lemmen, S., Panse, J., Rohde, H., Klupp, E. -M., Schafhausen, P., Imirzalioglu, C., Falgenhauer, L., Salmanton-Garcia, J., Stecher, M., Vehreschild, J. J., Seifert, H., Vehreschild, M. J. G. T., Biehl, L. M., Higgins, P., Wille, T., Peter, K., Hamprecht, A., Peter, S., Doerfel, D., Vogel, W., Haefner, H., Lemmen, S., Panse, J., Rohde, H., Klupp, E. -M., Schafhausen, P., Imirzalioglu, C., Falgenhauer, L., Salmanton-Garcia, J., Stecher, M., Vehreschild, J. J., Seifert, H., and Vehreschild, M. J. G. T.

Abstract

Objectives: Colonization and infection with third-generation cephalosporin-resistant Escherichia coli (3GCR-EC) are frequent in haematological and oncological patients. In this high-risk setting, German guidelines recommend single-room contact precautions (SCP) for patients with 3GCR-EC that are non-susceptible to fluoroquinolones (F3GCR-EC). However, this recommendation is controversial, as evidence is limited. Methods: We performed a prospective, multicentre cohort study at four haematology and oncology departments assessing the impact of SCP on hospital-acquired colonization or bloodstream infection (BSI) with F3GCR-EC. Two sites performed SCP for F3GCR-EC patients including single rooms, gloves and gowns (SCP sites), and two did not (NCP sites). Active screening for 3GCR-EC was performed and isolates were characterized with molecular typing methods including whole genome sequencing and core genome multiple locus sequence typing to assess patient-to-patient transmission. Potential confounders were assessed by competing-risk regression analysis. Results: Within 12 months, 1386 patients at NCP sites and 1582 patients at SCP sites were included. Hospital-acquisition of F3GCR-EC was observed in 22/1386 (1.59%) and 16/1582 (1.01%) patients, respectively (p 0.191). There were 3/1386 (0.22%) patients with BSI caused by F3GCR-EC at NCP sites and 4/1582 (0.25%) at SCP sites (p 1.000). Patient-to-patient transmission occurred in three cases at NCP and SCP sites each (p 1.000). The number of patients needed to screen in order to prevent one patient-to-patient transmission of F3GCR-EC was determined to be 3729. Conclusions: Use of SCP had no significant impact on hospital-acquisition or patient-to-patient transmission of F3GCR-EC in this high-risk setting. (C) 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Published
2019

39. Measurable patient benefit through digital healthcare networks for COVID-19 patients requiring intensive care in the Virtual Hospital NRW.

Author

Dohmen, S., Benstoem, C., Lemmen, S. W., Eisert, A., Zarbock, A., and Marx, G.

Subjects
COVID-19 pandemic, CRITICAL care medicine, FEASIBILITY studies, DIGITAL health, DATA protection
Abstract

Copyright of Anaesthesiologie & Intensivmedizin is the property of DGAI e.V. - Deutsche Gesellschaft fur Anasthesiologie und Intensivmedizin e.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results